Table 1.
Baseline characteristics.
| 6–23 Months | 24–59 Months | ||||
|---|---|---|---|---|---|
| Female | Male | Female | Male | Total | |
| Country | n (%) | n (%) | n (%) | n (%) | n (%) |
| Kenya | 495 (20.2) | 433 (19.6) | 355 (30.2) | 293 (27.0) | 1576 (22.8) |
| Chad | 878 (35.8) | 695 (31.3) | 223 (19.0) | 194 (17.8) | 1990 (28.7) |
| South Sudan | 767 (31.2) | 856 (38.7) | 333 (28.3) | 361 (33.2) | 2317 (15.1) |
| Yemen | 314 (12.8) | 228 (10.3) | 265 (22.5) | 239 (22.0) | 1046 (33.4) |
| Treatment site | |||||
| TFPa | 1327 (54.1) | 1272 (57.5) | 534 (45.4) | 521 (47.9) | 3654 (52.7) |
| SFPb | 1127 (45.9) | 940 (42.5) | 642 (54.6) | 566 (52.1) | 3275 (47.3) |
| Outcomes TFP | |||||
| Recovered | 928 (69.9) | 870 (68.4) | 365 (68.4) | 361 (69.3) | 2524 (69.1) |
| Death | 1 (0.1) | 3 (0.2) | 0 (NA) | 1 (0.2) | 5 (0.1) |
| Default | 240 (18.1) | 259 (20.4) | 118 (22.1) | 118 (22.6) | 735 (20.1) |
| Transfer | 122 (9.2) | 110 (8.6) | 45 (8.4) | 32 (6.1) | 309 (8.5) |
| Non‐response | 36 (2.7) | 30 (2.4) | 6 (1.1) | 9 (1.7) | 81 (2.2) |
| Outcomes SFP | |||||
| Recovered | 832 (73.8) | 700 (74.5) | 431 (67.1) | 370 (65.4) | 2333 (71.2) |
| Death | 3 (0.3) | 1 (0.1) | 3 (0.5) | 2 (0.3) | 9 (0.3) |
| Default | 176 (15.6) | 159 (16.9) | 182 (28.3) | 155 (27.4) | 672 (20.5) |
| Transfer | 102 (9.1) | 62 (6.6) | 19 (3.0) | 27 (4.8) | 210 (6.4) |
| Non‐response | 14 (1.2) | 18 (1.9) | 7 (1.1) | 12 (2.1) | 51 (1.6) |
| Totals | 2454 | 2212 | 1176 | 1087 | 6929 |
| No cases oedema in TFP | 7 (0.5) | 8 (0.6) | 16 (3.0) | 18 (3.5) | 49 (1.3) |
| Mean anthropometry TFP | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) |
|---|---|---|---|---|---|
| Baseline WHZ | −3.27 (1.04) | −3.67 (0.94) | −3.54 (0.76) | −3.80 (0.90) | −3.53 (0.97) |
| Baseline WAZ | −3.27 (0.98) | −3.59 (0.90) | −3.77 (1.05) | −3.78 (1.04) | −3.53 (1.00) |
| Baseline HAZ | −1.62 (1.60) | −1.90 (1.67) | −2.36 (1.69) | −2.46 (1.78) | −1.95 (1.69) |
| Baseline MUAC mm | 115.0 (8.28) | 117.0 (8.28) | 120.5 (9.36) | 121.5 (9.16) | 117.4 (8.92) |
| Mean anthropometry SFP | |||||
| Baseline WHZ | −1.78 (0.81) | −2.27 (0.86) | −2.02 (0.95) | −2.32 (0.94) | −2.06 (0.90) |
| Baseline WAZ | −2.31 (0.98) | −2.79 (0.95) | −2.65 (1.05) | −2.87 (0.98) | −2.61 (1.01) |
| Baseline HAZ | −1.75 (1.75) | −2.13 (1.86) | −2.12 (1.92) | −2.43 (1.75) | −2.05 (1.83) |
| Baseline MUAC mm | 122.1 (4.64) | 122.8 (5.21) | 126.7 (6.27) | 126.9 (6.54) | 124.0 (5.90) |
| Daily weight gain TFP g/kg/day | 5.14 (4.82) | 5.22 (5.42) | 5.79 (7.37) | 5.39 (5.79) | 5.30 (5.54) |
| Daily weight gain SFP g/kg/day | 2.93 (3.53) | 2.88 (4.03) | 2.91 (4.41) | 2.56 (3.20) | 2.85 (3.81) |
| Length of stay TFP days | 44.8 (28.4) | 45.2 (29.3) | 40.1 (32.9) | 42.5 (30.1) | 43.9 (29.7) |
| Length of stay SFP days | 50.0 (29.7) | 51.6 (32.8) | 52.2 (33.2) | 51.2 (34.0) | 51.0 (32.0) |
Abbreviations: SFP, supplementary feeding programmes; TFP, therapeutic feeding programmes.
a
Therapeutic feeding programme.
b
Supplementary feeding programme, percentages may not total 100 due to rounding.